209 related articles for article (PubMed ID: 8259801)
21. [Study of the antibodies against measles, rubella, mumps and varicella-zoster viruses in sera from the medical staffs].
Shiraishi T; Nakagawa M; Nakagawa Y; Tominaga M; Yoshitani S
Kansenshogaku Zasshi; 2005 May; 79(5):322-8. PubMed ID: 15977572
[TBL] [Abstract][Full Text] [Related]
22. The susceptibility of young adult Americans to vaccine-preventable infections. A national serosurvey of US Army recruits.
Kelley PW; Petruccelli BP; Stehr-Green P; Erickson RL; Mason CJ
JAMA; 1991 Nov; 266(19):2724-9. PubMed ID: 1942425
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
[TBL] [Abstract][Full Text] [Related]
24. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.
Socan M; Berginc N
Wien Klin Wochenschr; 2008; 120(13-14):422-6. PubMed ID: 18726668
[TBL] [Abstract][Full Text] [Related]
25. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
Alp E; Cevahir F; Gökahmetoglu S; Demiraslan H; Doganay M
J Infect Public Health; 2012 Apr; 5(2):127-32. PubMed ID: 22541258
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility in USAF recruits to vaccine-preventable diseases.
Clardy WF
Vaccine; 1993; 11(5):573-5. PubMed ID: 8488713
[TBL] [Abstract][Full Text] [Related]
27. Evidence of vaccine protection among thai medical students and implications for occupational health.
Srichomkwun P; Apisarnthanarak A; Thongphubeth K; Yuekyen C; Mundy LM
Infect Control Hosp Epidemiol; 2009 Jun; 30(6):585-8. PubMed ID: 19419330
[TBL] [Abstract][Full Text] [Related]
28. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
[TBL] [Abstract][Full Text] [Related]
29. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of measles, mumps, rubella and varicella among staff of a hospital in Riyadh, Saudi Arabia.
Abbas M; Atwa M; Emara A
J Egypt Public Health Assoc; 2007; 82(3-4):283-97. PubMed ID: 18410713
[TBL] [Abstract][Full Text] [Related]
31. Immunity of nursing students to measles, mumps, rubella, and varicella in Yozgat, Turkey.
Kader Ç; Erbay A; Akça NK; Polat MF; Polat S
Am J Infect Control; 2016 Jan; 44(1):e5-7. PubMed ID: 26442461
[TBL] [Abstract][Full Text] [Related]
32. The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.
Durando P; Esposito S; Bona G; Cuccia M; Desole MG; Ferrera G; Gabutti G; Pellegrino A; Salvini F; Henry O; Povey M; Marchetti F
Vaccine; 2016 Aug; 34(36):4278-84. PubMed ID: 27423382
[TBL] [Abstract][Full Text] [Related]
33. The combination measles, mumps, rubella and varicella vaccine in healthy children.
Arbeter AM; Baker L; Starr SE; Plotkin SA
Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the seroprevalence of measles, rubella, mumps, and varicella and the requirement for additional vaccination based on the JSIPC guidelines among emergency medical technicians at eight fire stations in Narita, Japan: a project review.
Hase R; Niiyama Y; Mito H
Hum Vaccin Immunother; 2022 Dec; 18(1):1989922. PubMed ID: 34756159
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
36. [Risks for measles and mumps in recruits of the Croatian army].
Perić D; Gotovac P
Lijec Vjesn; 2002 Oct; 124(10):301-4. PubMed ID: 12619438
[TBL] [Abstract][Full Text] [Related]
37. [Susceptibility to measles and varicella in healthcare workers in a tertiary hospital in Catalonia].
Fernández-Cano MI; Armadans L; Sulleiro E; Espuga M; Ferrer E; Martínez-Gómez X; Vaqué J; Campins M
Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):184-8. PubMed ID: 22137370
[TBL] [Abstract][Full Text] [Related]
38. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
Celikbas A; Ergonul O; Aksaray S; Tuygun N; Esener H; Tanir G; Eren S; Baykam N; Guvener E; Dokuzoguz B
Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
[TBL] [Abstract][Full Text] [Related]
39. Measles, mumps, rubella, and varicella among service members and other beneficiaries of the Military Health System, 1 January 2016-30 June 2019.
Williams VF; Stahlman S; Fan M
MSMR; 2019 Oct; 26(10):2-12. PubMed ID: 31657583
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia.
Almuneef MA; Memish ZA; Balkhy HH; Otaibi B; Helmi M
Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1178-83. PubMed ID: 17080374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
